Notably, EMP3 knockdown in melanoma C32 cells inhibited Akt phosphorylation and cell viability, indicating that the effect of EMP3 on Akt signaling and the role of EMP3 in malignancies are tumor-specific [30]. The gene discussed is AKT1; the disease is melanoma.